What is Shenzhen Lifotronic Technology Co., Ltd.'s (688389.SS) StockRank?

MoatMap's StockRank for Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) is 68/100, with a Buy signal. This is a composite score combining Quality (68), Value (38), and Momentum (49) factor ranks across MoatMap's 20,000+ stock universe.

Does Shenzhen Lifotronic Technology Co., Ltd. have an economic moat?

Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Shenzhen Lifotronic Technology Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) is Buy, based on a StockRank of 68/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Shenzhen Lifotronic Technology Co., Ltd. in?

Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688389.SS

BUYREMOVE

Shenzhen Lifotronic Technology Co., Ltd. · Healthcare · China · $745M · Avg Vol: $4M/d

StockRank

P/E (TTM)

28.7x

ROE

7.4%

D/E

0.1x

Dividend %

2.6%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Shenzhen Lifotronic is a Chinese medical device manufacturer. It lacks a global regulatory moat and does not align with our high-conviction CDMO or advanced packaging themes.

COMPANY DESCRIPTION

Shenzhen Lifotronic Technology Co., Ltd. develops and manufactures medical devices, specializing in wound treatment, pain rehabilitation, and in-vitro diagnostic (IVD) systems. The company has established a strong market position in China's clinical rehabilitation sector and is expanding rapidly in the high-growth IVD market with its specific protein analyzers. It operates as a diversified medical device player with a robust distribution network across domestic hospitals.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	145M	169M	170M	153M	1.8%
EPS	0.09	0.11	0.12	0.06	-10.5%
Shares	422M	428M	428M	428M	+1.5%
Debt	20M	36M	89M	59M	44.2%
Equity	213M	266M	303M	313M	13.7%
Op CF	40M	45M	44M	42M	1.1%
Inv CF	-79M	-9M	-9M	-31M	—
Fin CF	8M	15M	39M	-47M	—

PRICE (1M)-19.1%

SMA 50SMA 200

$1.56

RSI (14)

19.1

52W High

$2.15

From 52W High

0.7%

SCORE BREAKDOWN

Quality

ROIC

8.6%69.1

ROE

7.4%64.0

GP/Assets

23.8%54.4

Op. Margin

19.7%81.9

FCF/Assets

3.2%62.8

Piotroski

—83.4

Int. Cover

50.0x91.5

D/E Ratio

0.07x71.0

Current Ratio

4.34x66.4

Value

P/E (TTM)

28.7x38.6

EV/EBITDA

18.4x21.2

P/FCF

381.2x21.0

P/B

2.2x52.3

P/S

4.3x45.0

Div Yield

2.6%61.2

Momentum

52W High %

72%60.5

RS 6M

-30%41.8

SMA 50/200

0.92x39.4

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—88.7

Q Growth

-40%14.4

FUNDAMENTALS

Market Cap

$745M

P/E (Forward)

9.2x

Gross Margin

61.5%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 688389.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
688389.SS	Shenzhen Lifotronic Technology Co., Ltd.(you)	$745M	68	BUY
688236.SS	Beijing Chunlizhengda Medical Instruments Co., Ltd.	$920M	69	BUY
2172.HK	MicroPort NeuroScientific Corporation	$675M	73	BUY
688581.SS	Hangzhou AGS MedTech Co., Ltd.	$671M	73	BUY
300482.SZ	Guangzhou Wondfo Biotech Co.,Ltd	$1.2B	66	BUY
2235.HK	MicroTech Medical (Hangzhou) Co., Ltd.	$385M	70	BUY
2190.HK	Zylox-Tonbridge Medical Technology Co., Ltd.	$853M	82	STRONG BUY
1763.HK	China Isotope & Radiation Corporation	$734M	85	STRONG BUY
2291.HK	LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.	$425M	74	BUY
1302.HK	LifeTech Scientific Corporation	$932M	84	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.6x · Gross margin 53.0%

Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) — Stock Score Summary

Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) has a MoatMap StockRank of 68/100 based on Quality (68/100), Value (38/100), and Momentum (49/100) factor scores. The current signal is BUY. Shenzhen Lifotronic is a Chinese medical device manufacturer. It lacks a global regulatory moat and does not align with our high-conviction CDMO or advanced packaging themes.

Key Financial Metrics

Price	$1.56
Market Cap	$745M
P/E (TTM)	28.68
P/E (Forward)	9.16
Price/Book	2.17
Return on Equity	7.4%
Return on Invested Capital	8.6%
Debt/Equity	6.99
Gross Margin	61.5%
Operating Margin	19.7%
Revenue Growth	20.9%
Dividend Yield	2.6%
Free Cash Flow	$2M

Shenzhen Lifotronic Technology Co., Ltd. operates in the Medical Devices industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shenzhen Lifotronic Technology Co., Ltd.’s (688389.SS) StockRank?: MoatMap’s StockRank for Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) is 68/100, with a Buy signal. It is a composite of Quality (68), Value (38), and Momentum (49) factor ranks across MoatMap’s 20,000+ stock universe.
Does Shenzhen Lifotronic Technology Co., Ltd. have an economic moat?: Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shenzhen Lifotronic Technology Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) is Buy, based on a StockRank of 68/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shenzhen Lifotronic Technology Co., Ltd. in?: Shenzhen Lifotronic Technology Co., Ltd. (688389.SS) operates in the Healthcare sector, specifically the Medical Devices industry (China).